Betsy Mulé

Our roots are in one of America’s great entrepreneurial success stories. Fidelity Investments was founded in 1946 and grew from a single mutual fund into one of the largest asset management firms in the world, with over $2 trillion in assets under management. For the last forty years, our venture capital group has had the privilege of backing other great entrepreneurs as they built ground-breaking companies in technology and life sciences, including Atari, MCI, ROLM Corp., Alibaba, Ironwood Pharmaceuticals, and Ultragenyx. Today our funds are larger and more global, but our teams are still small and local. We stay true to our entrepreneurial roots. In the US and Europe, we are F-Prime Capital investing in healthcare (formerly Fidelity Biosciences) and in technology (formerly part of Devonshire Investors). In other geographies, our sister fund is called Eight Roads (formerly Fidelity Growth Partners), with investment teams in London, Shanghai, Beijing, Hong Kong, Tokyo, and Mumbai. Together we bring a world of insight, domain expertise and relationships to support our entrepreneurs. Without the pressure of fundraising from outside investors, we focus all of our time finding and helping great entrepreneurs build important companies.

The Emerging Venture Capitalists Association (EVCA) is a nonprofit dedicated to supporting the next generation of leaders in the venture capital industry. EVCA is the primary community for the emerging (pre-partner & junior partner) venture capital investor. Founded in 2017, our 1300+ investors come from a diverse assortment of backgrounds to share insights on industry verticals, co-investment opportunities, career planning, community service, and personal interests.

Our roots are in one of America’s great entrepreneurial success stories. Fidelity Investments was founded in 1946 and grew from a single mutual fund into one of the largest asset management firms in the world, with over $2 trillion in assets under management. For the last forty years, our venture capital group has had the privilege of backing other great entrepreneurs as they built ground-breaking companies in technology and life sciences, including Atari, MCI, ROLM Corp., Alibaba, Ironwood Pharmaceuticals, and Ultragenyx. Today our funds are larger and more global, but our teams are still small and local. We stay true to our entrepreneurial roots. In the US and Europe, we are F-Prime Capital investing in healthcare (formerly Fidelity Biosciences) and in technology (formerly part of Devonshire Investors). In other geographies, our sister fund is called Eight Roads (formerly Fidelity Growth Partners), with investment teams in London, Shanghai, Beijing, Hong Kong, Tokyo, and Mumbai. Together we bring a world of insight, domain expertise and relationships to support our entrepreneurs. Without the pressure of fundraising from outside investors, we focus all of our time finding and helping great entrepreneurs build important companies.

Mars & Co is a unique global force in the Strategy Consulting industry – yet keeps a low profile: • Small enough to be personal, yet serving many of the world’s largest corporations; • Providing clients with deep expertise, extremely valuable insights and actionable advice, yet only serving one client in any given industry on a long-term exclusive basis; • Composed of ~ 250 highly skilled consultants, yet our consultants are generalists and not pigeon-holed into practice groups. They work across a variety of industries and business functions which allow them to understand businesses holistically. From our 7 offices in North America, Europe and Asia we continue to expand our roster of prestigious clients and train some of the finest minds in the consulting industry. At Mars & Co, consultants immediately get the opportunity to help provide high impact strategic and operational assistance to an elite group of mainly Fortune 100-sized companies while working with some of the best senior executives in the industry. Mars & Co was founded in 1979 by Dominique Mars, then a Director of The Boston Consulting Group. He resigned from the Board of BCG for a simple reason: he felt it was essential for a strategy consulting firm to guarantee the exclusivity of its services to each client, thus limiting itself to a select number of them. Because he couldnt steer his then-partners in such a direction, Dominique Mars founded Mars & Co. Since its inception, Mars & Cos goals have never changed. Its major "raison dêtre"​ has remained to bring competitive leverage to a very limited number of clients and serve them worldwide on an exclusive basis - the only consulting firm of any consequence to guarantee "fidelity"​. Mars & Co has an atmosphere where professionalism, individual initiative, creativity and analytical rigor are all highly prized and well rewarded in the pursuit of making our clients the most successful firms in their industries